Utama › Fibrosis Kistik › Wisconsin
Kajian klinikal Fibrosis Kistik di Wisconsin
7 kajian untuk Fibrosis Kistik sedang mencari peserta di lokasi di Wisconsin.
Bandar di Wisconsin
Teks kajian rasmi (Bahasa Inggeris)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
- University of Wisconsin, Madison
- Froedtert & Medical College of Wisconsin, Milwaukee
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07450547Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- University of Wisconsin, Madison
- Children's Wisconsin & Medical College of Wisconsin, Milwaukee
Mengambil peserta
Umur 3 hingga 18 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06654752Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
- The Medical College of Wisconsin, Milwaukee
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT06560463Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- University of Wisconsin, Madison
Mengambil pesertaKajian pemerhatian
Sehingga umur 10 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- University of Wisconsin, Madison
Mengambil pesertaFasa 4
Umur 6 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT05548283Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
- Froedtert & Medical College of Wisconsin, Milwaukee
Mengambil pesertaKajian pemerhatian
Umur 16 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT07312734A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- University of Wisconsin, Madison
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 1 Okt 2025 · NCT06504589Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.